COMMUNIQUÉS West-GlobeNewswire

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it [...]
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
WALTHAM, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron Renaud, [...]
CG Oncology to Present at Upcoming Investor Conferences in June
28/05/2026
DALLAS, May 28, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the [...]
rYojbaba Rings the Nasdaq Stock Market Opening Bell, Celebrating Its Mission to “Fight Poverty” on the Global Stage
28/05/2026
CEO Ryoji Baba shares the company’s vision of combining the Samurai Spirit with AI and technology to break language barriers and create opportunities for the next generation FUKUOKA, Japan, May 28, 2026 (GLOBE NEWSWIRE [...]
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
LA JOLLA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that [...]
LB Pharmaceuticals to Participate in Upcoming June Investor Events
28/05/2026
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
Assembly Biosciences Announces Upcoming Investor Conference Presentations
28/05/2026
SOUTH SAN FRANCISCO, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
28/05/2026
ZUG, Switzerland, May 28, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment Notification of managers' [...]
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
28/05/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that the Company received a written notice (“Notice”) from the Nasdaq [...]
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
28/05/2026
BRISBANE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company” or “Pacira”), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform [...]
Repairon annonce la publication dans le NEJM des résultats de l’essai clinique BIOVAT-HF, une thérapie innovante pour l’insuffisance cardiaque avancée
28/05/2026
Repairon annonce la publication dans le New England Journal of Medicine des résultats d’un essai clinique évaluant du tissu musculaire cardiaque humain artificiel GÖTTINGEN, Allemagne et PROVIDENCE, Rhode Island, 28 mai [...]
Medline Inc. announces closing of upsized secondary offering of Class A common stock
28/05/2026
NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.’s Class A common stock by [...]
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
28/05/2026
Real-world analysis of three years of closed claims data from Symphony Health, focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data demonstrate a [...]
Tarsus to Participate in Upcoming Investor Conferences
28/05/2026
IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 46 th [...]
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
28/05/2026
Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in [...]
Keeps TRT Claims Evaluated: Clinician-Prescribed Testosterone Replacement Therapy Medication Online
28/05/2026
Compounded Testosterone Medication, Injectable TRT, Oral TRT, Enclomiphene Off-Label, Lab Panel, FDA Status, Pricing, and Telehealth Prescribing Rules (2026) New York, NY, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded [...]
Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
28/05/2026
DURHAM, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs, (“Pelthos [...]
Allogene Therapeutics Announces Planned CEO Succession
28/05/2026
David Chang, M.D., Ph.D., to Transition from President and Chief Executive Officer Following Eight Years of Outstanding Leadership and Continue to Serve on the Board of Directors Zachary Roberts, M.D., Ph.D., EVP, [...]
Kane Biotech Announces First Quarter 2026 Financial Results
28/05/2026
WINNIPEG, Manitoba, May 28, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its first quarter 2026 financial results. First Quarter 2026 Financial [...]

Pages